Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

被引：36

作者：

Bresalier, Robert S. ^{[1
]}

Kopetz, Scott ^{[2
]}

Brenner, Dean E. ^{[3
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA

[3] Univ Michigan, Dept Med Oncol, Ann Arbor, MI 48109 USA

来源：

DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 03期

关键词：

Colon cancer; Screening; Blood-based markers; Fecal occult blood testing; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED ANTIGEN; SEPTIN; 9; DNA; COLON-CANCER; GLYCOPROTEIN MICROARRAYS; BINDING PROTEIN-3; POTENTIAL MARKER; PLASMA-INSULIN; FACTOR-I; SERUM;

D O I：

10.1007/s10620-015-3575-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10 % of the total cancer burden with an individual lifetime risk of similar to 6 % in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.

引用

页码：664 / 671

页数：8

共 66 条

[11] A circulating ligand for galectin-3 glycoprotein elevated in individual is a haptoglobin-related with colon cancer [J].

Bresalier, RS ;

Byrd, JC ;

Tessler, D ;

Lebel, J ;

Koomen, J ;

Hawke, D ;

Half, E ;

Liu, KF ;

Mazurek, N .

GASTROENTEROLOGY, 2004, 127 (03) :741-748

[12] Vascular endothelial growth factor (VEGF) -: a valuable serum tumour marker in patients with colorectal cancer? [J].

Broll, R ;

Erdmann, H ;

Duchrow, M ;

Oeverman, E ;

Schwandner, O ;

Markert, U ;

Bruch, HP ;

Windhövel, U .

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (01) :37-42

[13]

Chen Y, 2007, INT J ONCOL, V30, P1137

[14] Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer [J].

Church, Timothy Robert ;

Wandell, Michael ;

Lofton-Day, Catherine ;

Mongin, Steven J. ;

Burger, Matthias ;

Payne, Shannon R. ;

Castanos-Velez, Esmeralda ;

Blumenstein, Brent A. ;

Roesch, Thomas ;

Osborn, Neal ;

Snover, Dale ;

Day, Robert W. ;

Ransohoff, David F. .

GUT, 2014, 63 (02) :317-325

[15] Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles [J].

Colombo, Marina ;

Raposo, Graca ;

Thery, Clotilde .

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30, 2014, 30 :255-289

[16] Loss of imprinting of insulin growth factor II gene: A potential heritable biomarker for colon neoplasia predisposition [J].

Cruz-Correa, M ;

Cui, HM ;

Giardiello, FM ;

Powe, NR ;

Hylind, L ;

Robinson, A ;

Hutcheon, DF ;

Kafonek, DR ;

Brandenburg, S ;

Wu, YQ ;

He, XB ;

Feinberg, AP .

GASTROENTEROLOGY, 2004, 126 (04) :964-970

[17] Loss of IGF2 imprinting:: A potential marker of colorectal cancer risk [J].

Cui, HM ;

Cruz-Correa, M ;

Giardiello, FM ;

Hutcheon, DF ;

Kafonek, DR ;

Brandenburg, S ;

Wu, YQ ;

He, XB ;

Powe, NR ;

Feinberg, AP .

SCIENCE, 2003, 299 (5613) :1753-1755

[18]

Cui HM, 2002, CANCER RES, V62, P6442

[19] Detection and quantification of mutations in the plasma of patients with colorectal tumors [J].

Diehl, F ;

Li, M ;

Dressman, D ;

He, YP ;

Shen, D ;

Szabo, S ;

Diaz, LA ;

Goodman, SN ;

David, KA ;

Juhl, H ;

Kinzler, KW ;

Vogelstein, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (45) :16368-16373

[20] A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases [J].

Feldman, AL ;

Alexander, HR ;

Bartlett, DL ;

Kranda, KC ;

Miller, MS ;

Costouros, NG ;

Choyke, PL ;

Libutti, SK .

ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (09) :741-745

← 1 2 3 4 5 6 7 →